Diagnostic and surgical approaches to treating the disease are evolving — just as rates are spiking. Learn how the surgical ...

In pMMR/MSS colon cancer, neoadjuvant BOT+BAL met the trial’s primary endpoint with a 36% major pathologic response rate, including 29% pathologic complete response, within an overall 71% pathologic ...

UNICORN Challenges Immunotherapy Resistance in MSS Colon Cancer / Agenus, Balstilimab, botensilimab, cancer, Colon cancer, colorectal cancer, ctDNA, Filippo ...

If it might be cancer, please take a sample and clarify it quickly.This is a phrase I often hear from patients and their families when pancreatic cancer is suspected.It is very natural to feel that ...

IntroductionThere is something I would like endoscopists in their 30s to consider for a moment."How many more years can you ...

A new Cell Division study reports that linalool stabilizes the NR3C2 protein in gastric cancer cells, activating NFKBIZ and ...

Researchers report that the RNA-processing protein ALYREF binds poly-ADP-ribose at DNA double-strand breaks, delaying repair ...

What presented as a partial bowel obstruction was something much rarer, according to British surgeons, who found that an infant with abdominal distention, vomiting and constipation, actually had a ...

Using an intestinal ultrasound may help patients avoid having to undergo invasive procedures, like colonoscopies, as often.

For patients undergoing elective intestinal resection for Crohn disease (CD), cumulative surgical recurrence rates are lower ...

A 49-year-old woman with alcohol-related cirrhosis (Child-Pugh B8, MELD 11) and 11 months of abstinence presented with per ...